Subscribe to our Email List






Previous. All pages. Next. 1. 2. 3. 4. 5. 6. Page 7. 8

29 May 2007 Verona Pharma plc Commences Pre-Clinical Studies of its Lead Compound RPL554
09 May 2007 Verona Pharma Appoints WH Ireland as Nominated Adviser and Broker
26 Apr 2007 Preliminary Results for year ended 31 December 2006
20 Mar 2007 Material Transfer Agreement with HepMim Biosciences
05 Feb 2007 Change of Director Shareholding
22 Jan 2007 Verona Pharma Engages Onyx Scientific to Manufacture RPL554 for Preclinical (Toxicology) and Clinical Studies
15 Dec 2006 Total Voting Rights and Share Capital
15 Dec 2006 Update on NAIPs Programme
27 Nov 2006 Verona Pharma plc Advances RPL554 Drug Development Project for Treatment of Respiratory Diseases
16 Nov 2006 Verona Pharma signs Material Transfer Agreement with Glycomar for NAIPs programme

Previous. All pages. Next. 1. 2. 3. 4. 5. 6. Page 7. 8

 

Home      Company Information      Products      AIM Rule 26      News Releases      Contact      For Staff


©2006 Verona Pharma Plc All Rights Reserved. | Disclaimer